VEGFA and neoplasm: This unique composition of expressed genes supports the presence of a profound distinction between tumor-related activities of hAAT and benign conditions in its presence; islet grafts and endothelial cells were shown to express elevated levels of VEGF in the presence of hAAT (84), agreeing with the fact that the promoter for hAAT is hypoxia-responsive (85).